Under this pathophysiological mechanism, the concurrence of ALS phenotype and motion hyperactivity phenotype may be reasonable in patients with FUS p.P525L defects that trigger the dysfunction of nuclear mass transport and protein deposits (Koutsis, Karadima, Kartanou, Kladi, & Panas, 2015). Here, FUS is linked to amyotrophic lateral sclerosis.